Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients
复制标题
DOI：
10.1111/liv.12199
复制
发表时间：
2013-11-01
影响因子：
6.7
通讯作者：
Trevisani, Franco
中科院分区：
文献类型：
--
作者：
Giannini, Edoardo G.;Savarino, Vincenzo;Trevisani, Franco
背景：临床上显著的门静脉高压对肝细胞癌（HCC）切除术后肝硬化患者预后的作用仍有争议。在这项研究中，我们的目的是评估临床上显著的门静脉高压症在肝硬化患者肝切除术后的作用。方法我们评估了存在临床显著的门静脉高压症（食管/胃静脉曲张/门静脉高压性胃病或血小板计数100 vs 86个月，P=0.742）的预后作用。结论存在临床显著的门静脉高压症对行肝切除术的肝硬化患者的生存没有影响。
Background The role of clinically significant portal hypertension on the prognosis of cirrhotic patients undergoing hepatic resection for hepatocellular carcinoma (HCC) is debated. Aims In this study, our aim was to assess the role of clinically significant portal hypertension after hepatic resection for HCC in patients with cirrhosis. Methods We assessed the prognostic role of the presence of clinically significant portal hypertension (oesophageal/gastric varices/portal hypertensive gastropathy or a platelet count 100 vs 86months, P=0.742).Conclusions Presence of clinically significant portal hypertension has no influence on survival of patients with well-compensated cirrhosis undergoing hepatic resection for HCC.